Trial intelligence / Profile preview

Effects of contraception on uterine and ovarian blood flow

2010-020372-30Phase 4Terminated

Sponsor
Tommi Vimpeli
Start
May 2010
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of avatrombopag, etonogestrel, ethinyl estradiol + desogestrel, desogestrel and etonogestrel + ethinyl estradiol in contraception (5 arms), sponsored by Tommi Vimpeli. Started May 2010; status: terminated.

02

Drugs

avatrombopagetonogestrelethinyl estradiol + desogestreldesogestreletonogestrel + ethinyl estradiol
03

Conditions

contraception

Beyond the preview

Go deeper on 2010-020372-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020372-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call